600671 天目药业
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)8.61528.79734.061-339.450-441.328
总资产报酬率 ROA (%)1.4103.9893.871-11.798-19.148
投入资产回报率 ROIC (%)2.3427.4408.055-28.512-49.337

边际利润分析
销售毛利率 (%)50.37947.76347.38021.78722.934
营业利润率 (%)4.5653.96311.557-30.851-64.168
息税前利润/营业总收入 (%)11.7228.17615.771-23.961-59.650
净利润/营业总收入 (%)4.9733.40210.062-32.268-67.143

收益指标分析
经营活动净收益/利润总额(%)75.68994.27397.72681.95350.760
价值变动净收益/利润总额(%)-0.06716.7110.0991.448-1.333
营业外收支净额/利润总额(%)45.25117.91513.618-3.4683.431

偿债能力分析
流动比率 (X)0.8400.8090.7780.8240.561
速动比率 (X)0.7070.6700.5950.6290.346
资产负债率 (%)78.11678.73680.74283.84398.493
带息债务/全部投入资本 (%)50.86046.72944.11732.81442.978
股东权益/带息债务 (%)52.89758.84454.19070.998-31.116
股东权益/负债合计 (%)21.60920.11514.69612.791-4.895
利息保障倍数 (X)3.4642.4426.594-4.092-8.776

营运能力分析
应收账款周转天数 (天)237.052204.353110.37899.756135.909
存货周转天数 (天)142.010148.910149.976171.044214.290